Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Nasally delivered flu vaccine safe and immunogenic in adults

Oct. 30, 1998

Phase III study evaluates efficacy of tacrolimus in bone marrow transplantation

Oct. 29, 1998

Aquila's malaria vaccine immunogenic and well tolerated in phase I trial

Oct. 28, 1998

Vasogen files for protection of patient-specific treatment of GvHD

Oct. 27, 1998

Simulect gets the go-ahead from the European Commission

Oct. 23, 1998

Astra patents novel immunosuppressive agents

Oct. 22, 1998

Oxo Chemie initiates phase III trial of compound for late-stage HIV infection

Oct. 21, 1998

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Certiva vaccine launched in the U.S.

Oct. 16, 1998

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...